Free beta access. 5 free AI tokens each week. Optional top-ups available. See what is included
Opening Word document…

CBD solves biotech research, agriculture, burden sharing, and biodiversity

BIO 22(Biotechnology Innovation Organization, BIO is the world’s largest advocacy association representing member companies, state biotechnology groups, academic and research institutions, and related organizations across the United States and in 30+ countries, “The Biosafety Protocol-An Overview”, https://archive.bio.org/articles/biosafety-protocol-overview, Accessed June 19, 2022)//AS

“Desired Outcomes Biodiversity is a global resource of tremendous value to all of humankind. The CBD provides an important opportunity for nations to work together on an issue vitally important to us and future generations. To that end, we support a BSP that furthers the goals of the CBD: The conservation and sustainable use of biodiversity and equitable sharing of the benefits of biotechnology. To contribute to these goals, the BSP must: Be based on sound scientific principles. Take into account the actual environmental risks and the benefits of biotechnology, especially its role in facilitating biodiversity conservation. Focus on the transboundary movement of LMOs that may threaten biodiversity. Not unnecessarily restrict the transboundary movement of LMOs that pose no threat to biodiversity, thus increasing costs and delays without compensatory increases in environmental protection. Be consistent with existing international obligations to protect the environment. Encourage technology transfer and information sharing so all countries can benefit from advances in medical, agricultural and environmental biotechnology, while, at the same time, allowing for the protection of confidential information and intellectual property. Not divert resources from the protection of biodiversity to the development and administration of a regulatory system requiring case-by-case review of low-risk products. Be flexible so that any country can respond rapidly and appropriately to favorable developments in the new and evolving field of biotechnology.”

Sign in to recut, update, or save this card.